ORIFARM GENERICS A/S — Credit Rating and Financial Key Figures

ORIFARM GENERICS A/S (CVR number: 25674030) is a company from ODENSE. The company reported a net sales of 2343 mDKK in 2024, demonstrating a growth of 4.2 % compared to the previous year. The operating profit percentage was at 4.2 % (EBIT: 99.1 mDKK), while net earnings were 59.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 10.1 %, which can be considered good and Return on Equity (ROE) was 11.4 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 53.3 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. ORIFARM GENERICS A/S's liquidity measured by quick ratio was 0.8 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.